HEADER TRANSCRIPTION 11-JUN-20 6ZCI TITLE CRYSTAL STRUCTURE OF BRD4-BD1 IN COMPLEX WITH NVS-BET-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CHROMATIN BINDING, BROMODOMAIN, ACETYLATED HISTONE BINDING, KEYWDS 2 TRANSCRIPTION REGULATION, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR M.FALLER REVDAT 4 24-JAN-24 6ZCI 1 REMARK REVDAT 3 03-MAR-21 6ZCI 1 JRNL REVDAT 2 03-FEB-21 6ZCI 1 JRNL REVDAT 1 23-DEC-20 6ZCI 0 JRNL AUTH G.SCHUTZIUS,C.KOLTER,S.BERGLING,F.TORTELLI,F.FUCHS,S.RENNER, JRNL AUTH 2 V.GUAGNANO,S.COTESTA,H.RUEEGER,M.FALLER,L.BOUCHEZ,A.SALATHE, JRNL AUTH 3 F.NIGSCH,S.M.RICHARDS,M.LOUIS,V.GRUBER,A.AEBI,J.TURNER, JRNL AUTH 4 F.GRANDJEAN,J.LI,C.DIMITRI,J.R.THOMAS,M.SCHIRLE,J.BLANK, JRNL AUTH 5 P.DRUECKES,A.VAUPEL,R.TIEDT,P.W.MANLEY,J.KLOPP,R.HEMMIG, JRNL AUTH 6 F.ZINK,N.LEROY,W.CARBONE,G.ROMA,C.G.KELLER,N.DALES, JRNL AUTH 7 A.BEYERBACH,A.ZIMMERLIN,D.BONENFANT,R.TERRANOVA,A.BERWICK, JRNL AUTH 8 S.SAHAMBI,A.REYNOLDS,L.L.JENNINGS,H.RUFFNER,P.TARSA, JRNL AUTH 9 T.BOUWMEESTER,V.DRIVER,M.FREDERIKSEN,F.LOHMANN,S.KIRKLAND JRNL TITL BET BROMODOMAIN INHIBITORS REGULATE KERATINOCYTE PLASTICITY. JRNL REF NAT.CHEM.BIOL. V. 17 280 2021 JRNL REFN ESSN 1552-4469 JRNL PMID 33462494 JRNL DOI 10.1038/S41589-020-00716-Z REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (3-OCT-2019) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 83.8 REMARK 3 NUMBER OF REFLECTIONS : 8490 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 408 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.54 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2703 REMARK 3 BIN FREE R VALUE : 0.4472 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 21 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 994 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.42770 REMARK 3 B22 (A**2) : -6.62450 REMARK 3 B33 (A**2) : 10.05220 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.273 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.239 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.208 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.863 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1057 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1455 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 331 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 173 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1057 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 140 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 909 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.78 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.49 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.68 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -11.6128 2.6071 -9.4903 REMARK 3 T TENSOR REMARK 3 T11: -0.0492 T22: -0.0648 REMARK 3 T33: -0.0982 T12: 0.034 REMARK 3 T13: -0.025 T23: -0.0217 REMARK 3 L TENSOR REMARK 3 L11: 2.7308 L22: 2.317 REMARK 3 L33: 3.6144 L12: -0.0651 REMARK 3 L13: 0.9972 L23: -0.9082 REMARK 3 S TENSOR REMARK 3 S11: 0.0642 S12: -0.0756 S13: -0.1715 REMARK 3 S21: -0.0756 S22: -0.1498 S23: -0.001 REMARK 3 S31: -0.1715 S32: -0.001 S33: 0.0856 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZCI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292109287. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8489 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 38.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.6 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.03401 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3MXF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 200 MM SODIUM MALONATE REMARK 280 PH 5.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.30750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.27600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.02900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.27600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.30750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 22.02900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 HIS A 27 REMARK 465 SER A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 VAL A 31 REMARK 465 ASP A 32 REMARK 465 LEU A 33 REMARK 465 GLY A 34 REMARK 465 THR A 35 REMARK 465 GLU A 36 REMARK 465 ASN A 37 REMARK 465 LEU A 38 REMARK 465 TYR A 39 REMARK 465 PHE A 40 REMARK 465 GLN A 41 REMARK 465 GLU A 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 GLN A 59 CG CD OE1 NE2 REMARK 470 ARG A 68 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 LYS A 76 CD CE NZ REMARK 470 ASN A 93 CG OD1 ND2 REMARK 470 LYS A 112 CG CD CE NZ REMARK 470 ASN A 117 CG OD1 ND2 REMARK 470 GLN A 123 CG CD OE1 NE2 REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 ASP A 145 CG OD1 OD2 REMARK 470 GLN A 159 CG CD OE1 NE2 REMARK 470 GLU A 163 CG CD OE1 OE2 REMARK 470 GLU A 167 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 301 O HOH A 325 1.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 94 79.97 -119.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QFN A 201 DBREF 6ZCI A 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 6ZCI MET A 21 UNP O60885 INITIATING METHIONINE SEQADV 6ZCI HIS A 22 UNP O60885 EXPRESSION TAG SEQADV 6ZCI HIS A 23 UNP O60885 EXPRESSION TAG SEQADV 6ZCI HIS A 24 UNP O60885 EXPRESSION TAG SEQADV 6ZCI HIS A 25 UNP O60885 EXPRESSION TAG SEQADV 6ZCI HIS A 26 UNP O60885 EXPRESSION TAG SEQADV 6ZCI HIS A 27 UNP O60885 EXPRESSION TAG SEQADV 6ZCI SER A 28 UNP O60885 EXPRESSION TAG SEQADV 6ZCI SER A 29 UNP O60885 EXPRESSION TAG SEQADV 6ZCI GLY A 30 UNP O60885 EXPRESSION TAG SEQADV 6ZCI VAL A 31 UNP O60885 EXPRESSION TAG SEQADV 6ZCI ASP A 32 UNP O60885 EXPRESSION TAG SEQADV 6ZCI LEU A 33 UNP O60885 EXPRESSION TAG SEQADV 6ZCI GLY A 34 UNP O60885 EXPRESSION TAG SEQADV 6ZCI THR A 35 UNP O60885 EXPRESSION TAG SEQADV 6ZCI GLU A 36 UNP O60885 EXPRESSION TAG SEQADV 6ZCI ASN A 37 UNP O60885 EXPRESSION TAG SEQADV 6ZCI LEU A 38 UNP O60885 EXPRESSION TAG SEQADV 6ZCI TYR A 39 UNP O60885 EXPRESSION TAG SEQADV 6ZCI PHE A 40 UNP O60885 EXPRESSION TAG SEQADV 6ZCI GLN A 41 UNP O60885 EXPRESSION TAG SEQADV 6ZCI SER A 42 UNP O60885 EXPRESSION TAG SEQADV 6ZCI MET A 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 148 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 148 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASN PRO PRO SEQRES 3 A 148 PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG GLN SEQRES 4 A 148 THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU LYS SEQRES 5 A 148 THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN GLN SEQRES 6 A 148 PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR TYR SEQRES 7 A 148 LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE LYS SEQRES 8 A 148 LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN GLU SEQRES 9 A 148 CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR SEQRES 10 A 148 ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET ALA SEQRES 11 A 148 GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN GLU SEQRES 12 A 148 LEU PRO THR GLU GLU HET QFN A 201 29 HETNAM QFN (4~{R})-4-(4-CHLOROPHENYL)-1-CYCLOPROPYL-5-(1,5- HETNAM 2 QFN DIMETHYL-6-OXIDANYLIDENE-PYRIDIN-3-YL)-3-METHYL-4~{H}- HETNAM 3 QFN PYRROLO[3,4-C]PYRAZOL-6-ONE FORMUL 2 QFN C22 H21 CL N4 O2 FORMUL 3 HOH *104(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 LYS A 76 1 8 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 GLU A 163 1 20 SITE 1 AC1 15 TRP A 81 PRO A 82 PHE A 83 GLN A 85 SITE 2 AC1 15 LEU A 92 ASP A 96 LYS A 99 ILE A 100 SITE 3 AC1 15 TYR A 139 ASN A 140 ASP A 145 ILE A 146 SITE 4 AC1 15 MET A 149 HOH A 306 HOH A 308 CRYST1 38.615 44.058 80.552 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025897 0.000000 0.000000 0.00000 SCALE2 0.000000 0.022697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012414 0.00000